Halofuginone (HF), a febrifugine derivative sourced from the traditional medicinal plant Dichroa febrifuga Lour., which significantly inhibited the viability of CRC cells, was observed to inactivate G6PD within the PPP posttreatment. The gene discussed is G6PD; the disease is colorectal carcinoma.